Perseus Proteomics (TSE:4882) Net Income (Continuing Operations) : 円-1,104.5 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Perseus Proteomics's Net Income (Continuing Operations) for the three months ended in Sep. 2024 was 円0.0 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was 円-1,104.5 Mil.

Perseus Proteomics Net Income (Continuing Operations) Historical Data

The historical data trend for Perseus Proteomics's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Net Income (Continuing Operations) Chart

Perseus Proteomics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-841.73

-413.22

-599.02

-787.00

-1,104.46

Perseus Proteomics Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Net Income (Continuing Operations)	Get a 7-Day Free Trial													-422.12	-211.36	-266.23	-204.74	-

Perseus Proteomics Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,104.5 Mil.

Perseus Proteomics (TSE:4882) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Perseus Proteomics Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Perseus Proteomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041

Website

https://www.ppmx.com

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics Headlines

No Headlines